The bile acid TUDCA and neurodegenerative disorders: An overview
Bear bile has been used in Traditional Chinese Medicine for thousands of years due to its
therapeutic potential and clinical applications. The tauroursodeoxycholic acid (TUDCA), one …
therapeutic potential and clinical applications. The tauroursodeoxycholic acid (TUDCA), one …
Alzheimer's disease and diabetes: insulin signaling as the bridge linking two pathologies
JCC Shieh, PT Huang, YF Lin - Molecular neurobiology, 2020 - Springer
Alzheimer's (or Alzheimer) disease (AD) is the most prevalent subset of dementia, affecting
elderly populations worldwide. The cumulative costs of the AD care are rapidly accelerating …
elderly populations worldwide. The cumulative costs of the AD care are rapidly accelerating …
Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimer's disease during lifespan
C Bäuerl, MC Collado, A Diaz Cuevas… - Letters in applied …, 2018 - academic.oup.com
Alzheimer's disease (AD) is the most common form of dementia and one of the major causes
of disability and dependency in older people. Accumulating evidences link gut microbiota …
of disability and dependency in older people. Accumulating evidences link gut microbiota …
Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders
The prevalence of somatic insulinopathies, like metabolic syndrome (MetS), obesity, and
type 2 diabetes mellitus (T2DM), is higher in Alzheimer's disease (AD), autism spectrum …
type 2 diabetes mellitus (T2DM), is higher in Alzheimer's disease (AD), autism spectrum …
[HTML][HTML] Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders
J Olloquequi, A Cano, E Sanchez-López… - Biomedicine & …, 2022 - Elsevier
Protein tyrosine phosphatase 1B (PTP1B) is a typical member of the PTP family, considered
a direct negative regulator of several receptor and receptor-associated tyrosine kinases …
a direct negative regulator of several receptor and receptor-associated tyrosine kinases …
Branched-chain amino acids are linked with Alzheimer's disease-related pathology and cognitive deficits
MAB Siddik, CA Mullins, A Kramer, H Shah… - Cells, 2022 - mdpi.com
Alzheimer's disease (AD) is an irreversible neurodegenerative disorder with a complex
pathophysiology. Type 2 diabetes (T2D) is a strong risk factor for AD that shares similar …
pathophysiology. Type 2 diabetes (T2D) is a strong risk factor for AD that shares similar …
[HTML][HTML] Sex differences in the IntelliCage and the Morris water maze in the APP/PS1 mouse model of amyloidosis
MA Mifflin, W Winslow, L Surendra, S Tallino… - Neurobiology of …, 2021 - Elsevier
Transgenic rodent models were created to decipher pathogenic mechanisms associated
with Alzheimer's disease (AD), and behavioral apparatuses such as the Morris water maze …
with Alzheimer's disease (AD), and behavioral apparatuses such as the Morris water maze …
The effect of dietary fat consumption on Alzheimer's disease pathogenesis in mouse models
A Amelianchik, L Sweetland-Martin… - Translational Psychiatry, 2022 - nature.com
Alzheimer's disease (AD) is a fatal cognitive disorder with proteinaceous brain deposits,
neuroinflammation, cerebrovascular dysfunction, and extensive neuronal loss over time. AD …
neuroinflammation, cerebrovascular dysfunction, and extensive neuronal loss over time. AD …
Functions of amyloid precursor protein in metabolic diseases
Y Guo, Q Wang, S Chen, C Xu - Metabolism, 2021 - Elsevier
Amyloid precursor protein (APP) is a transmembrane precursor protein that is widely
expressed in the central nervous system and peripheral tissues in the liver and pancreas …
expressed in the central nervous system and peripheral tissues in the liver and pancreas …
[HTML][HTML] AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice
M Khandelwal, K Manglani, P Upadhyay, M Azad… - Neurobiology of …, 2022 - Elsevier
Alzheimer's disease (AD) is a progressive devastating neurodegenerative disorder
characterized by extracellular amyloid beta (Aβ 42) plaque formation, hyperphosphorylation …
characterized by extracellular amyloid beta (Aβ 42) plaque formation, hyperphosphorylation …